| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60505-6249-1 | 60505-6249 | HUMAN PRESCRIPTION DRUG | Dexamethasone | Dexamethasone | TABLET | ORAL | 20231205 | N/A | ANDA | ANDA217695 | Apotex Corp. | DEXAMETHASONE | .5 mg/1 | 100 TABLET in 1 BOTTLE (60505-6249-1) |
| 60505-6250-1 | 60505-6250 | HUMAN PRESCRIPTION DRUG | Dexamethasone | Dexamethasone | TABLET | ORAL | 20231205 | N/A | ANDA | ANDA217695 | Apotex Corp. | DEXAMETHASONE | .75 mg/1 | 100 TABLET in 1 BOTTLE (60505-6250-1) |
| 60505-6251-1 | 60505-6251 | HUMAN PRESCRIPTION DRUG | Dexamethasone | Dexamethasone | TABLET | ORAL | 20231101 | N/A | ANDA | ANDA217695 | Apotex Corp. | DEXAMETHASONE | 1 mg/1 | 100 TABLET in 1 BOTTLE (60505-6251-1) |
| 60505-6252-1 | 60505-6252 | HUMAN PRESCRIPTION DRUG | Dexamethasone | Dexamethasone | TABLET | ORAL | 20231205 | N/A | ANDA | ANDA217695 | Apotex Corp. | DEXAMETHASONE | 1.5 mg/1 | 100 TABLET in 1 BOTTLE (60505-6252-1) |
| 60505-6253-1 | 60505-6253 | HUMAN PRESCRIPTION DRUG | Dexamethasone | Dexamethasone | TABLET | ORAL | 20231101 | N/A | ANDA | ANDA217695 | Apotex Corp. | DEXAMETHASONE | 2 mg/1 | 100 TABLET in 1 BOTTLE (60505-6253-1) |
| 60505-6254-1 | 60505-6254 | HUMAN PRESCRIPTION DRUG | Dexamethasone | Dexamethasone | TABLET | ORAL | 20231101 | N/A | ANDA | ANDA217695 | Apotex Corp. | DEXAMETHASONE | 4 mg/1 | 100 TABLET in 1 BOTTLE (60505-6254-1) |
| 60505-6255-1 | 60505-6255 | HUMAN PRESCRIPTION DRUG | Dexamethasone | Dexamethasone | TABLET | ORAL | 20231205 | N/A | ANDA | ANDA217695 | Apotex Corp. | DEXAMETHASONE | 6 mg/1 | 100 TABLET in 1 BOTTLE (60505-6255-1) |